EU Still Resisting COVID-19 Vaccine IP Waiver
EFPIA 'Deeply Concerned' About Compulsory Licensing Proposal
The pharmaceutical industry and Médecins Sans Frontières have both criticized the EU’s proposals for avoiding a waiver of intellectual property rights on COVID-19 vaccines and treatments, albeit for different reasons.
